A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Basal-bolus Therapy in Subjects With Type 2 Diabetes Mellitus

Clinical trial NCT02420262 · COMPLETED

Trial details

NCT number

NCT02420262

Sponsor

Novo Nordisk A/S

Status

COMPLETED

Phase

Phase 3

Study type

INTERVENTIONAL

Start date

2015-07-26

Primary completion

2016-10-05

Enrollment

506

View on ClinicalTrials.gov